Effect of mosapride combined with esomeprazole improves esophageal peristaltic function in patients with gastroesophageal reflux disease: A study using high resolution manometry

Digestive Diseases and Sciences

Volumn 58, Issue 4, 2013, Pages 1035-1041

  Cho, Yu Kyung ^a   Choi, Myung Gyu ^a   Park, Eun Young ^a   Lim, Chul Hyun ^a   Kim, Jin Su ^a   Park, Jae Myung ^a   Lee, In Seok ^a   Kim, Sang Woo ^a   Choi, Kyu Yong ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Esophageal motility; Gastroesophageal reflux; Mosapride

Indexed keywords

ESOMEPRAZOLE; MOSAPRIDE; PLACEBO;

ADULT; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DYSPEPSIA; ESOPHAGUS MANOMETRY; ESOPHAGUS MOTILITY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; LOWER ESOPHAGUS SPHINCTER PRESSURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOM ASSESSMENT; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; ANTI-ULCER AGENTS; BENZAMIDES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ESOMEPRAZOLE SODIUM; ESOPHAGUS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MANOMETRY; MIDDLE AGED; MORPHOLINES; PERISTALSIS; PROTON PUMP INHIBITORS; SEROTONIN RECEPTOR AGONISTS;

EID: 84876666787     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2430-y     Document Type: Article

References (13)

1. Fock KM, Talley NJ, Fass R, et al. Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol. 2008;23:8-22.
2. Cucchiara S, Staiano A, Boccieri A, et al. Effects of cisapride on parameters of oesophageal motility and on the prolonged intraoesophageal pH test in infants with gastro-oesophageal reflux disease. Gut. 1990;31:21-25.
3. Goldin GF, Marcinkiewicz M, Zbroch T, Bityutskiy LP, McCallum RW, Sarosiek J. Esophagoprotective potential of cisapride. An additional benefit for gastroesophageal reflux disease. Dig Dis Sci. 1997;42:1362-1369.
4. Ruth M, Finizia C, Cange L, Lundell L. The effect of mosapride on oesophageal motor function and acid reflux in patients with gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol. 2003;15:1115-1121.
5. Cho YK, Choi MG, Han HW, et al. The effect of mosapride on esophageal motility and bolus transit in asymptomatic volunteers. J Clin Gastroenterol. 2006;40:286-292.
6. Koshino K, Adachi K, Furuta K, et al. Effects of mosapride on esophageal functions and gastroesophageal reflux. J Gastroenterol Hepatol. 2010;25:1066-1071.
7. Futagami S, Iwakiri K, Shindo T, et al. The prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptying. J Gastroenterol. 2010;45:413-421.
8. Miwa H, Inoue K, Ashida K, et al. Randomised clinical trial: efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non-erosive reflux disease - a double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2011;33:323-332.
9. Chen CL, Yi CH. Utility of esophageal impedance in identifying dysmotility in patients with erosive esophagitis. Dis Esophagus. 2008;21:539-543.
10. Clouse RE, Staiano A, Alrakawi A, Haroian L. Application of topographical methods to clinical esophageal manometry. Am J Gastroenterol. 2000;95:2720-2730.
11. Murray JA, Clouse RE, Conklin JL. Components of the standard oesophageal manometry. Neurogastroenterol Motil. 2003;15:591-606.
12. Ghosh SK, Janiak P, Schwizer W, Hebbard GS, Brasseur JG. Physiology of the esophageal pressure transition zone: separate contraction waves above and below. Am J Physiol Gastrointest Liver Physiol. 2006;290:G568-G576.
13. Fox M, Menne D, Stutz B, Fried M, Schwizer W. The effects of tegaserod on oesophageal function and bolus transport in healthy volunteers: studies using concurrent high-resolution manometry and videofluoroscopy. Aliment Pharmacol Ther. 2006;24:1017-1027.